Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
05/2003
05/06/2003US6559100 2-benzoyl-cyclohexane-1,3-diones
05/02/2003EP1306086A2 Use of thiazolidinediones for the treatment of atherosclerosis and eating disorders
05/02/2003EP1305304A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor
05/02/2003EP1305301A1 Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators
05/02/2003EP1305292A1 Biphenyl carboxamides
05/02/2003EP1305024A1 Method for treating fibrotic diseases or other indications ic
05/02/2003EP0797439B1 Use of pramipexole as a neuroprotective agent
05/01/2003WO2003035629A1 Thiopene- amd thiazolesulfonamides as antineoplastic agents
05/01/2003WO2003035627A1 Piperazine derivatives with ccr1 receptor antagonist activity
05/01/2003WO2003035613A2 Nitrogen heterocycle inhibitors of aspartyl protease
05/01/2003WO2003035610A1 Sulfonamide derivative having mmp inhibitory activity
05/01/2003WO2003035609A1 Zwitterionic imides
05/01/2003WO2003035602A1 Lipid modulators
05/01/2003WO2003035067A1 Novel dipeptidyl peptidase iv (dp-iv) inhibitors as anti-diabetic agents
05/01/2003WO2003035057A1 Inhibitors of dipeptidyl peptidase iv
05/01/2003WO2003006443A3 2- 4-(naphtalin-2-yl)-thiazol-2-ylaminocarbonyl benzoic acid and 2- 4-(naphtalin-2-yl)-pyrimidin-2-ylaminocarbonyl benzoic acid and additional compounds serving as telomerase inhibitors for use in tumor therapy
05/01/2003WO2002100351A3 A method for treating inflammatory diseases by administering a ppar-delta agonist
05/01/2003WO2002005834A3 Novel uses for thyroid hormones or thyroid hormone-like agonist compounds for treating dermis conditions
05/01/2003US20030083504 N- (4-carbamimidoyl-phenyl) -glycine derivatives
05/01/2003US20030083358 Agents for combating plant pests
05/01/2003US20030083356 Statine derivatives for the treatment of Alzheimer's disease
05/01/2003US20030083353 Beta-secretase inhibitors
05/01/2003US20030083349 Antimalaria agents
05/01/2003US20030083331 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
05/01/2003US20030083267 For inhibiting the binding of ligands to antigens; prophylaxis and treatment of inflammatory and autoimmune diseases such as asthma, arthritis, psoriasis, transplantation rejection, multiple sclerosis, diabetes, and inflammatory bowel disease
05/01/2003US20030082631 Detecting modulator of peroxisome proliferator-activated receptor; obtain sample contain proxisome receptor, incubate with test agent, monitor sample for adjustment in receptor activity
05/01/2003CA2464256A1 Novel dipeptidyl peptidase iv (dp-iv) inhibitors as anti-diabetic agents
05/01/2003CA2464254A1 Inhibitors of post-proline cleaving proteases
05/01/2003CA2463290A1 Zwitterionic imides
04/2003
04/30/2003CN1414951A Drug discharge pump inhibitors
04/30/2003CN1107059C Azole derivative
04/29/2003US6555690 Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
04/29/2003CA2134347C Thiazole or imidazole derivatives as maillard reaction inhibitors
04/25/2003CA2426925A1 Water-soluble liquid internal medicine
04/24/2003WO2003032980A1 5'-carbamoyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
04/24/2003WO2003032972A1 5’-carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
04/24/2003WO2003032971A1 5’-acylamino-1,1’-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
04/24/2003WO2003032916A2 Organosulfur inhibitors of tyrosine phosphatases
04/24/2003WO2002098850A3 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
04/24/2003WO2002058690A3 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
04/24/2003US20030078440 O- or S- substituted tetrahydronaphthalene derivatives useful as regulators of cell proliferation and differentiation, useful for treating skin-related diseases
04/24/2003US20030078433 Process for preparing 4,5-dihydro-1,3-thiazoles
04/24/2003US20030078430 Process for preparing 1,4-dihydropyridine compounds
04/24/2003US20030078420 New derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
04/24/2003US20030078287 For controlling plant and animal pests
04/24/2003US20030078261 Prostaglandin agonists
04/24/2003US20030078252 Used to treat abnormal cell growth and central nervous system disorders
04/24/2003US20030078249 VLA-4 inhibitor compounds
04/24/2003US20030078247 Enzyme inhibitor of a dipeptidyl peptidase for treating hyperglycaemia
04/24/2003US20030078235 Treatment of central nervous system disorders; anticonvulsants, antiepileptics, neuroprotective agents and muscle relaxants
04/24/2003US20030078193 Therapeutic Agents For Diabetes
04/24/2003CA2463724A1 Organosulfur inhibitors of tyrosine phosphatases
04/23/2003EP1304327A2 Glutamine-thiazolidide and -pyrrolidide and their use as dipeptidylpeptidase IV inhibitors
04/23/2003EP1303513A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases
04/23/2003EP1303509A1 Beta3 adrenergic agonists
04/23/2003EP1303502A2 Tetrahydrobenzothiazole analogues as neuroprotective agents
04/23/2003EP1303501A1 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging
04/23/2003EP1303483A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same
04/23/2003EP1303272A2 Benzothiazole derivatives
04/23/2003EP1303270A1 Method for treating cryptorchidism
04/23/2003EP1086179B1 Energy transfer assay method and reagent
04/23/2003EP1082314B1 New dipeptidyl peptidase iv effectors
04/23/2003EP0993442B1 Hydrazine derivatives
04/23/2003EP0889881B1 New triazoles as therapeutic agents for fungal infections
04/23/2003CN1413210A Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
04/23/2003CN1413201A Thiazolylcinnamonitrile compounds and insecticides and miticides
04/23/2003CN1413200A Cyanomethylene compounds, process for producing the same, and agricultural or horticultural bactericide
04/23/2003CN1413195A Immunoassay detection method for neonicotinyl insecticides
04/23/2003CN1413193A Nitrile derivatives as cathepsin K inhibitors
04/23/2003CN1106381C Preparation process of nitroguanidine derivatives
04/23/2003CN1106195C Use of thazolinedione derivatives and related antihyperglycemic agents in treatment of disease states at risk for progressing to non-insulin-dependent diabetes mellitus
04/22/2003US6552216 Molecular model for VLA-4 inhibitors
04/22/2003US6552058 Oxazolidinedione derivatives and their use
04/22/2003US6552047 H2 receptor antagonist compounds in combination with nitric oxide donors, compositions and methods of use
04/22/2003US6552022 Atherosclerosis in a mammal, pancreatitis, non-insulin dependent diabetes mellitus, coronary heart disease in a lowering serum lipid levels
04/22/2003US6551682 Proper tracking error signals to be adapted to high density information recording and has various characteristics
04/22/2003CA2253951C .delta.1,2bicyclo[4,4,0] functional dyes for contrast enhancement in optical imaging
04/17/2003WO2003031449A2 Cross-linked glycopeptide-cephalosporin antibiotics
04/17/2003WO2003031421A1 Process for preparation of ethene derivatives
04/17/2003WO2003031414A1 Novel heterocyclic compound and anti-inflammatory agent
04/17/2003WO2003031410A1 Ligands of melanocortin receptors and compositions and methods related thereto
04/17/2003WO2003031397A1 Acylsulfonamides as inhibitors of steroid sulfatase
04/17/2003WO2003030889A1 Para-amino benzoic acids as integrin antagonists
04/17/2003WO2003013484A3 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents
04/17/2003WO1999043212A3 Wood preservatives
04/17/2003US20030073862 Antidiabetic agents, anticancer agents, anticholesterol agents
04/17/2003US20030073850 Incontinence; nasal congestion
04/17/2003US20030073847 Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
04/17/2003US20030073836 Heteroarylcarboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions
04/17/2003US20030073832 Novel aminophenyl ketone derivatives
04/17/2003US20030073725 Naphtalene derivatives and their pharmaceutical use
04/17/2003US20030073722 Pyrazole substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
04/17/2003US20030073712 Antiinflamamtory agents; antiischemic agents
04/17/2003US20030073685 Nitric oxide synthase inhibitor; antiinflammatory agents
04/17/2003US20030070240 N-heteroarylmethyl-p-phnylendiamine derivatives and compounds containing oxidationcoloring agents
04/17/2003CA2462301A1 Para-amino benzoic acids as integrin antagonists
04/17/2003CA2458453A1 Acylsulfonamides as inhibitors of steroid sulfatase
04/16/2003EP1302468A1 Processes and intermediates for manufacturing retroviral protease inhibiting compounds
04/16/2003EP1302467A2 Process for the preparation of substituted thiazoline derivatives and their intermediate
04/16/2003EP1301506A1 Cyclic amino acid derivatives
1 ... 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 ... 337